Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.
Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E.
Shirakawa K, et al. Among authors: marmorstein r.
Elife. 2016 May 31;5:e11156. doi: 10.7554/eLife.11156.
Elife. 2016.
PMID: 27244239
Free PMC article.